VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 160 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 12.90 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $11,196 | -25.2% | 1,515 | 0.0% | 0.00% | -33.3% |
| Q3 2022 | $14,968 | +74.0% | 1,515 | +92.0% | 0.01% | +100.0% |
| Q2 2022 | $8,600 | +2.3% | 789 | +47.2% | 0.00% | 0.0% |
| Q4 2021 | $8,410 | -3.2% | 536 | +5.7% | 0.00% | 0.0% |
| Q3 2021 | $8,690 | -9.4% | 507 | +13.7% | 0.00% | -25.0% |
| Q2 2021 | $9,593 | +107.6% | 446 | +10.4% | 0.00% | +100.0% |
| Q2 2020 | $4,622 | -57.8% | 404 | -39.4% | 0.00% | -66.7% |
| Q4 2019 | $10,945 | -13.3% | 667 | -25.6% | 0.01% | -14.3% |
| Q2 2019 | $12,625 | -29.0% | 896 | -7.2% | 0.01% | -30.0% |
| Q1 2019 | $17,774 | -29.6% | 966 | 0.0% | 0.01% | -37.5% |
| Q4 2018 | $25,242 | – | 966 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 4,658,759 | $121,733,000 | 8.95% |
| Palo Alto Investors LP | 4,155,670 | $108,588,000 | 5.78% |
| Stonepine Capital Management, LLC | 220,848 | $5,771,000 | 5.07% |
| Birchview Capital, LP | 80,000 | $2,090,000 | 1.98% |
| EAM Global Investors LLC | 75,310 | $1,968,000 | 1.08% |
| Atika Capital Management LLC | 130,000 | $3,397,000 | 1.00% |
| EAM Investors, LLC | 110,806 | $2,895,000 | 0.79% |
| UNIVERSITY OF NOTRE DAME DU LAC | 97,521 | $2,548,000 | 0.62% |
| ALGERT GLOBAL LLC | 76,204 | $1,991,000 | 0.56% |
| 361 CAPITAL LLC | 85,885 | $2,244,000 | 0.46% |